Endocrinology, Vol 132, 2578-2585, Copyright © 1993 by Endocrine Society

ARTICLES

Regulation of extracellular signal-regulated protein kinase-1 (ERK-1; pp44/mitogen-activated protein kinase) by epidermal growth factor and nerve growth factor in PC12 cells: implication of ERK1 inhibitory activities

P Peraldi, JC Scimeca, C Filloux and E Van Obberghen
INSERM U 145, Faculte de Medecine, Nice, France.

In PC12 cells, extracellular signal-regulated kinase-1 (ERK1 or pp44/mitogen-activated protein kinase) is stimulated in response to epidermal growth factor (EGF) and nerve growth factor (NGF). This stimulation is rapid and short-lived after EGF activation. In contrast, NGF promotes a swift, but persistent, ERK1 stimulation. We took advantage of this difference in activation pattern to study the negative regulation of ERK1. Using antibodies to the C-terminus of ERK1, we performed in vitro reconstitution experiments with immunoprecipitated ERK1 from stimulated cells and extracts from PC12 cells incubated with EGF or NGF for various periods of times. Using this approach, we showed that extracts from unstimulated cells reduce ERK1 activity. Upon exposure of cells to NGF or EGF, we found that the inhibitory activity had a pattern opposite that of ERK1 phosphorylation and activity. Indeed, the highest ERK1 activation was associated with the lowest ERK1-repressing activity and vice versa. This ERK1 inhibitory activity was found to be sensitive mainly to sodium orthovanadate and to a lesser extent to zinc acetate. Interestingly, okadaic acid decreased ERK1-repressing activity from unstimulated cells when tested with ERK1 from 5-min NGF-treated cells, but not with ERK1 from 5-min EGF-treated cells. Hence, ERK1 appears to be regulated differently after stimulation of cells with EGF compared to NGF. We show that cell extracts promote ERK1 dephosphorylation. Indeed, we were able to detect a phosphatase activity toward in vivo phosphorylated ERK1 that was regulated differently after NGF and EGF treatments of the cells, and that has a profile of regulation similar to that of the ERK1 inhibitory activity. This regulatable phosphatase activity was also observed using in vitro phosphorylated ERK1. Taken together, our data provide evidence that ERK1 is negatively controlled by a phosphatase(s) that can undergo differential modulation depending on the stimuli used.

This article has been cited by other articles:

				R. Zhande, W. Zhang, Y. Zheng, E. Pendleton, Y. Li, R. D. Polakiewicz, and X. J. Sun Dephosphorylation by Default, a Potential Mechanism for Regulation of Insulin Receptor Substrate-1/2, Akt, and ERK1/2 J. Biol. Chem., December 22, 2006; 281(51): 39071 - 39080. [Abstract] [Full Text] [PDF]

				C. S. Lim, S. H. Kim, J. G. Jung, J.-K. Kim, and W. K. Song Regulation of SPIN90 Phosphorylation and Interaction with Nck by ERK and Cell Adhesion J. Biol. Chem., December 26, 2003; 278(52): 52116 - 52123. [Abstract] [Full Text] [PDF]

				S. J. Yarwood and J. R. Woodgett Extracellular matrix composition determines the transcriptional response to epidermal growth factor receptor activation PNAS, March 29, 2001; (2001) 81069098. [Abstract] [Full Text]

				J. L. Todd, K. G. Tanner, and J. M. Denu Extracellular Regulated Kinases (ERK) 1 and ERK2 Are Authentic Substrates for the Dual-specificity Protein-tyrosine Phosphatase VHR. A NOVEL ROLE IN DOWN-REGULATING THE ERK PATHWAY J. Biol. Chem., May 7, 1999; 274(19): 13271 - 13280. [Abstract] [Full Text] [PDF]

				F. Vinals and J. Pouyssegur Confluence of Vascular Endothelial Cells Induces Cell Cycle Exit by Inhibiting p42/p44 Mitogen-Activated Protein Kinase Activity Mol. Cell. Biol., April 1, 1999; 19(4): 2763 - 2772. [Abstract] [Full Text] [PDF]

				T. Yamauchi, Y. Kaburagi, K. Ueki, Y. Tsuji, G. R. Stark, I. M. Kerr, T. Tsushima, Y. Akanuma, I. Komuro, K. Tobe, et al. Growth Hormone and Prolactin Stimulate Tyrosine Phosphorylation of Insulin Receptor Substrate-1, -2, and -3, Their Association with p85 Phosphatidylinositol 3-Kinase (PI3-kinase), and Concomitantly PI3-kinase Activation via JAK2 Kinase J. Biol. Chem., June 19, 1998; 273(25): 15719 - 15726. [Abstract] [Full Text] [PDF]

				F. Renaud, S. Desset, L. Oliver, G. Gimenez-Gallego, E. Van Obberghen, Y. Courtois, and M. Laurent The Neurotrophic Activity of Fibroblast Growth Factor 1 (FGF1) Depends on Endogenous FGF1 Expression and Is Independent of the Mitogen-activated Protein Kinase Cascade Pathway J. Biol. Chem., February 2, 1996; 271(5): 2801 - 2811. [Abstract] [Full Text] [PDF]

				J. VanderKuur, G. Allevato, N. Billestrup, G. Norstedt, and C. Carter-Su Growth Hormone-promoted Tyrosyl Phosphorylation of SHC Proteins and SHC Association with Grb2 J. Biol. Chem., March 31, 1995; 270(13): 7587 - 7593. [Abstract] [Full Text] [PDF]

				A. D. Cherniack, J. K. Klarlund, B. R. Conway, and M. P. Czech Disassembly of Son-of-sevenless Proteins from Grb2 during p21[IMAGE] Desensitization by Insulin J. Biol. Chem., January 27, 1995; 270(4): 1485 - 1488. [Abstract] [Full Text] [PDF]

				S. P. Kwak and J. E. Dixon Multiple Dual Specificity Protein Tyrosine Phosphatases Are Expressed and Regulated Differentially in Liver Cell Lines J. Biol. Chem., January 20, 1995; 270(3): 1156 - 1160. [Abstract] [Full Text] [PDF]

				L. L. Tortorella, D. J. Milasincic, and P. F. Pilch Critical Proliferation-independent Window for Basic Fibroblast Growth Factor Repression of Myogenesis via the p42/p44 MAPK Signaling Pathway J. Biol. Chem., April 20, 2001; 276(17): 13709 - 13717. [Abstract] [Full Text] [PDF]

				A. Liu, M. S. Prenger, D. D. Norton, L. Mei, J. W. Kusiak, and G. Bai Nerve Growth Factor Uses Ras/ERK and Phosphatidylinositol 3-Kinase Cascades to Up-regulate the N-Methyl-D-aspartate Receptor 1 Promoter J. Biol. Chem., November 21, 2001; 276(48): 45372 - 45379. [Abstract] [Full Text] [PDF]

				S. J. Yarwood and J. R. Woodgett Extracellular matrix composition determines the transcriptional response to epidermal growth factor receptor activation PNAS, April 10, 2001; 98(8): 4472 - 4477. [Abstract] [Full Text] [PDF]